Table 4.
Predictors of Quality of Life in Patients With Heart Failure
PRO Measure | Predictor | Unadjusted Effect β̂ (95% CI) | Adjusted Effect β̂ (95% CI) |
---|---|---|---|
EuroQol VAS | Peak VO2, 1 SD | 1.78 (0.99 to 2.57) | 2.86 (1.98 to 3.74) |
Six-minute walk, 1 SD | 2.15 (1.36 to 2.94) | 2.78 (1.92 to 3.64) | |
NYHA class II to III | −8.67 (−10.26 to −7.07) | −8.26 (−9.93 to −6.59) | |
KCCQ overall score | Peak VO2, 1 SD | 4.38 (3.55 to 5.21) | 4.75 (3.78 to 5.72) |
Six-minute walk, 1 SD | 5.57 (4.76 to 6.39) | 5.92 (4.98 to 6.87) | |
NYHA class II to III | −14.67 (−16.31 to −13.04) | −12.73 (−14.53 to −10.92) | |
KCCQ clinical summary | Peak VO2, 1 SD | 5.52 (4.75 to 6.29) | 5.41 (4.56 to 6.26) |
Six-minute walk, 1 SD | 6.29 (5.53 to 7.05) | 6.37 (5.51 to 7.22) | |
KCCQ subscales | |||
Physical limitation | Peak VO2, 1 SD | 6.77 (5.91 to 7.63) | 6.44 (5.47 to 7.42)† |
Six-minute walk, 1 SD | 7.59 (6.74 to 8.44) | 7.45 (6.48 to 8.43) | |
Total symptom | Peak VO2, 1 SD | 4.32 (3.48 to 5.16) | 4.39 (3.47 to 5.30) |
Six-minute walk, 1 SD | 5.07 (4.24 to 5.89) | 5.19 (4.26 to 6.13) | |
Social limitation | Peak VO2, 1 SD | 4.18 (3.06 to 5.31) | 5.27 (2.69 to 7.86)‡ |
Six-minute walk, 1 SD | 5.76 (4.65 to 6.88) | 6.21 (4.92 to 7.50) | |
Self–efficacy | Peak VO2, 1 SD | 0.99 (0.16 to 1.82) | 0.62 (−0.22 to 1.47) |
Six-minute walk, 1 SD | 0.95 (0.12 to 1.78) | 0.56 (−0.29 to 1.42) | |
Quality–of–life | Peak VO2, 1 SD | 2.50 (1.49 to 3.51) | 5.11 (2.71 to 7.51)‡ |
Six-minute walk, 1 SD | 4.10 (3.10 to 5.11) | 5.01 (3.85 to 6.16) |
Abbreviations: PRO, patient-reported outcome; CI, confidence interval; VAS, Visual Analog Scale; peak VO2, peak oxygen consumption during cardiopulmonary exercise testing; KCCQ, Kansas City Cardiomyopathy Questionnaire.
Adjusted for all significant patient characteristics listed in Table 1.
Significant interactions included peak VO2 with age and peak VO2 with ethnicity.
Significant interactions included peak VO2 with age, peak VO2 with employment status, and peak VO2 with marital status.